http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013129696-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L27-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L27-00 |
filingDate | 2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2013129696-A |
titleOfInvention | DELIVERY OF FUNCTIONAL CONNECTIONS |
abstract | 1. A composition comprising: a functional ingredient, wherein at least a portion of the functional ingredient is in the form of a modified functional ingredient selected from a salt of a functional ingredient, a complex of a functional ingredient, a glycoside of a functional ingredient and mixtures thereof; an inactive carrier; an enteral matrix, a microencapsulating functional ingredient and an inactive carrier and containing an edible enteric polymer; wherein the modified functional ingredient is intended for hydrolysis to form an initial, unmodified form of the functional ingredient. 2. The composition according to claim 1, characterized in that the functional ingredient includes at least one of the substances: linalool and thymol. A composition according to claim 1 or 2, characterized in that at least about 20% of the functional ingredient is in the form of a modified functional ingredient. A composition according to claim 1 or 2, characterized in that at least about 50% of the functional ingredient is in the form of a modified functional ingredient. The composition according to claim 1 or 2, characterized in that the inactive carrier is a lipid. The composition of claim 5, wherein the lipid is a triglyceride. A composition according to claim 6, characterized in that the triglyceride is selected from the group comprising soybean oil and canola oil. A composition according to any one of claims 1, 2, 6 or 7, characterized in that the ratio of the functional ingredient to the material of the enteric matrix varies from about 1:19 to about 1: 1.9. A composition according to any one of claims 1, 2, 6 or 7, characterized in that the enteral matrix is selected from the group consisting of |
priorityDate | 2010-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.